The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Medical Artificial Biological Heart Valve Market Research Report 2025
Synopsis
The global Medical Artificial Biological Heart Valve market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medical Artificial Biological Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Artificial Biological Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Artificial Biological Heart Valve include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, Corcym, CryoLife, Braile Biomédica, TTK Healthcare and Colibri Heart Valve, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Artificial Biological Heart Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Artificial Biological Heart Valve.
Report Scope
The Medical Artificial Biological Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Artificial Biological Heart Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Artificial Biological Heart Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Corcym
CryoLife
Braile Biomédica
TTK Healthcare
Colibri Heart Valve
JenaValve Technology
Meril Life Sciences
Beijing Balance Medical
CardiMED
Segment by Type
Stented Valve
Stentless Valve
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Artificial Biological Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Artificial Biological Heart Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Medical Artificial Biological Heart Valve market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medical Artificial Biological Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Artificial Biological Heart Valve is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medical Artificial Biological Heart Valve include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, Corcym, CryoLife, Braile Biomédica, TTK Healthcare and Colibri Heart Valve, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Artificial Biological Heart Valve, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Artificial Biological Heart Valve.
Report Scope
The Medical Artificial Biological Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Artificial Biological Heart Valve market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Artificial Biological Heart Valve manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Boston Scientific
Abbott
Corcym
CryoLife
Braile Biomédica
TTK Healthcare
Colibri Heart Valve
JenaValve Technology
Meril Life Sciences
Beijing Balance Medical
CardiMED
Segment by Type
Stented Valve
Stentless Valve
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Artificial Biological Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Artificial Biological Heart Valve in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Medical Artificial Biological Heart Valve Market Overview
1.1 Product Overview and Scope of Medical Artificial Biological Heart Valve
1.2 Medical Artificial Biological Heart Valve Segment by Type
1.2.1 Global Medical Artificial Biological Heart Valve Market Value Comparison by Type (2024-2030)
1.2.2 Stented Valve
1.2.3 Stentless Valve
1.3 Medical Artificial Biological Heart Valve Segment by Application
1.3.1 Global Medical Artificial Biological Heart Valve Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Medical Artificial Biological Heart Valve Market Size Estimates and Forecasts
1.4.1 Global Medical Artificial Biological Heart Valve Revenue 2019-2030
1.4.2 Global Medical Artificial Biological Heart Valve Sales 2019-2030
1.4.3 Global Medical Artificial Biological Heart Valve Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Artificial Biological Heart Valve Market Competition by Manufacturers
2.1 Global Medical Artificial Biological Heart Valve Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Artificial Biological Heart Valve Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Artificial Biological Heart Valve Average Price by Manufacturers (2019-2024)
2.4 Global Medical Artificial Biological Heart Valve Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Artificial Biological Heart Valve, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Artificial Biological Heart Valve, Product Type & Application
2.7 Medical Artificial Biological Heart Valve Market Competitive Situation and Trends
2.7.1 Medical Artificial Biological Heart Valve Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Artificial Biological Heart Valve Players Market Share by Revenue
2.7.3 Global Medical Artificial Biological Heart Valve Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Artificial Biological Heart Valve Retrospective Market Scenario by Region
3.1 Global Medical Artificial Biological Heart Valve Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Artificial Biological Heart Valve Global Medical Artificial Biological Heart Valve Sales by Region: 2019-2030
3.2.1 Global Medical Artificial Biological Heart Valve Sales by Region: 2019-2024
3.2.2 Global Medical Artificial Biological Heart Valve Sales by Region: 2025-2030
3.3 Global Medical Artificial Biological Heart Valve Global Medical Artificial Biological Heart Valve Revenue by Region: 2019-2030
3.3.1 Global Medical Artificial Biological Heart Valve Revenue by Region: 2019-2024
3.3.2 Global Medical Artificial Biological Heart Valve Revenue by Region: 2025-2030
3.4 North America Medical Artificial Biological Heart Valve Market Facts & Figures by Country
3.4.1 North America Medical Artificial Biological Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Artificial Biological Heart Valve Sales by Country (2019-2030)
3.4.3 North America Medical Artificial Biological Heart Valve Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Artificial Biological Heart Valve Market Facts & Figures by Country
3.5.1 Europe Medical Artificial Biological Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Artificial Biological Heart Valve Sales by Country (2019-2030)
3.5.3 Europe Medical Artificial Biological Heart Valve Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Medical Artificial Biological Heart Valve Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Artificial Biological Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Artificial Biological Heart Valve Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Artificial Biological Heart Valve Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Medical Artificial Biological Heart Valve Market Facts & Figures by Country
3.7.1 Latin America Medical Artificial Biological Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Artificial Biological Heart Valve Sales by Country (2019-2030)
3.7.3 Latin America Medical Artificial Biological Heart Valve Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Medical Artificial Biological Heart Valve Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Artificial Biological Heart Valve Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Artificial Biological Heart Valve Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Artificial Biological Heart Valve Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Artificial Biological Heart Valve Sales by Type (2019-2030)
4.1.1 Global Medical Artificial Biological Heart Valve Sales by Type (2019-2024)
4.1.2 Global Medical Artificial Biological Heart Valve Sales by Type (2025-2030)
4.1.3 Global Medical Artificial Biological Heart Valve Sales Market Share by Type (2019-2030)
4.2 Global Medical Artificial Biological Heart Valve Revenue by Type (2019-2030)
4.2.1 Global Medical Artificial Biological Heart Valve Revenue by Type (2019-2024)
4.2.2 Global Medical Artificial Biological Heart Valve Revenue by Type (2025-2030)
4.2.3 Global Medical Artificial Biological Heart Valve Revenue Market Share by Type (2019-2030)
4.3 Global Medical Artificial Biological Heart Valve Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Artificial Biological Heart Valve Sales by Application (2019-2030)
5.1.1 Global Medical Artificial Biological Heart Valve Sales by Application (2019-2024)
5.1.2 Global Medical Artificial Biological Heart Valve Sales by Application (2025-2030)
5.1.3 Global Medical Artificial Biological Heart Valve Sales Market Share by Application (2019-2030)
5.2 Global Medical Artificial Biological Heart Valve Revenue by Application (2019-2030)
5.2.1 Global Medical Artificial Biological Heart Valve Revenue by Application (2019-2024)
5.2.2 Global Medical Artificial Biological Heart Valve Revenue by Application (2025-2030)
5.2.3 Global Medical Artificial Biological Heart Valve Revenue Market Share by Application (2019-2030)
5.3 Global Medical Artificial Biological Heart Valve Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Edwards Lifesciences
6.1.1 Edwards Lifesciences Corporation Information
6.1.2 Edwards Lifesciences Description and Business Overview
6.1.3 Edwards Lifesciences Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Edwards Lifesciences Medical Artificial Biological Heart Valve Product Portfolio
6.1.5 Edwards Lifesciences Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Medical Artificial Biological Heart Valve Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Corporation Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Medical Artificial Biological Heart Valve Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Medical Artificial Biological Heart Valve Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Corcym
6.5.1 Corcym Corporation Information
6.5.2 Corcym Description and Business Overview
6.5.3 Corcym Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corcym Medical Artificial Biological Heart Valve Product Portfolio
6.5.5 Corcym Recent Developments/Updates
6.6 CryoLife
6.6.1 CryoLife Corporation Information
6.6.2 CryoLife Description and Business Overview
6.6.3 CryoLife Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CryoLife Medical Artificial Biological Heart Valve Product Portfolio
6.6.5 CryoLife Recent Developments/Updates
6.7 Braile Biomédica
6.6.1 Braile Biomédica Corporation Information
6.6.2 Braile Biomédica Description and Business Overview
6.6.3 Braile Biomédica Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Braile Biomédica Medical Artificial Biological Heart Valve Product Portfolio
6.7.5 Braile Biomédica Recent Developments/Updates
6.8 TTK Healthcare
6.8.1 TTK Healthcare Corporation Information
6.8.2 TTK Healthcare Description and Business Overview
6.8.3 TTK Healthcare Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TTK Healthcare Medical Artificial Biological Heart Valve Product Portfolio
6.8.5 TTK Healthcare Recent Developments/Updates
6.9 Colibri Heart Valve
6.9.1 Colibri Heart Valve Corporation Information
6.9.2 Colibri Heart Valve Description and Business Overview
6.9.3 Colibri Heart Valve Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Colibri Heart Valve Medical Artificial Biological Heart Valve Product Portfolio
6.9.5 Colibri Heart Valve Recent Developments/Updates
6.10 JenaValve Technology
6.10.1 JenaValve Technology Corporation Information
6.10.2 JenaValve Technology Description and Business Overview
6.10.3 JenaValve Technology Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.10.4 JenaValve Technology Medical Artificial Biological Heart Valve Product Portfolio
6.10.5 JenaValve Technology Recent Developments/Updates
6.11 Meril Life Sciences
6.11.1 Meril Life Sciences Corporation Information
6.11.2 Meril Life Sciences Medical Artificial Biological Heart Valve Description and Business Overview
6.11.3 Meril Life Sciences Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Meril Life Sciences Medical Artificial Biological Heart Valve Product Portfolio
6.11.5 Meril Life Sciences Recent Developments/Updates
6.12 Beijing Balance Medical
6.12.1 Beijing Balance Medical Corporation Information
6.12.2 Beijing Balance Medical Medical Artificial Biological Heart Valve Description and Business Overview
6.12.3 Beijing Balance Medical Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beijing Balance Medical Medical Artificial Biological Heart Valve Product Portfolio
6.12.5 Beijing Balance Medical Recent Developments/Updates
6.13 CardiMED
6.13.1 CardiMED Corporation Information
6.13.2 CardiMED Medical Artificial Biological Heart Valve Description and Business Overview
6.13.3 CardiMED Medical Artificial Biological Heart Valve Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CardiMED Medical Artificial Biological Heart Valve Product Portfolio
6.13.5 CardiMED Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Artificial Biological Heart Valve Industry Chain Analysis
7.2 Medical Artificial Biological Heart Valve Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Artificial Biological Heart Valve Production Mode & Process
7.4 Medical Artificial Biological Heart Valve Sales and Marketing
7.4.1 Medical Artificial Biological Heart Valve Sales Channels
7.4.2 Medical Artificial Biological Heart Valve Distributors
7.5 Medical Artificial Biological Heart Valve Customers
8 Medical Artificial Biological Heart Valve Market Dynamics
8.1 Medical Artificial Biological Heart Valve Industry Trends
8.2 Medical Artificial Biological Heart Valve Market Drivers
8.3 Medical Artificial Biological Heart Valve Market Challenges
8.4 Medical Artificial Biological Heart Valve Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
